Bloom Health Partners Announces Closing of Second Tranche of Private Placement for over C$1.58M in Aggregate Gross Proceeds Medical Device Investing
BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States Pharmaceutical Investing
Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pharmaceutical Investing
Johnson & Johnson's Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022 Pharmaceutical Investing
Seelos Therapeutics Doses First Patient in an Open Label Basket Study of SLS-005 in Amyotrophic Lateral Sclerosis in Australia and Provides an Enrollment Update of its Study on the HEALEY ALS Platform Psychedelics Investing
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical Life Science Investing
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine Pharmaceutical Investing
Medtronic expands Health Equity Assistance Program for colon cancer screening with support from Amazon Web Services; Completes first installation of donated GI Genius intelligent endoscopy modules Medical Device Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
